Medicaid Incentives for Prevention of Chronic Diseases (MIPCD) | Apply Online

Opportunity Summary:

The Medicaid Incentives for Prevention of Chronic Diseases (MIPCD) grant opportunity was a Centers for Medicare and Medicaid Services (CMS) discretionary grant program created under Section 4108 of the Affordable Care Act (Public Law 111-148). Its core purpose was to help states test and expand prevention-focused approaches in Medicaid by offering incentives to beneficiaries of any age who both participate in approved prevention programs and show measurable improvements in health risks or outcomes, including adopting healthier behaviors. A key feature of the program is that it ties incentives to engagement and demonstrated progress, aiming to reduce chronic disease burden and related costs by motivating preventive action early and consistently.

Under this opportunity, states were expected to propose initiatives that are comprehensive and evidence based, and that can realistically be accessed by Medicaid beneficiaries across the state. CMS emphasized that programs should be widely available and easily accessible rather than limited pilot activities that only reach a narrow population. Applicants were required to ground their program designs in established evidence-based resources, specifically referencing tools such as the Guide to Community Preventive Services, the Guide to Clinical Preventive Services, and the National Registry of Evidence-Based Programs. In practice, that requirement signaled that states needed to select interventions with a strong research foundation and credible implementation models, rather than inventing untested approaches.

State applications had to address at least one of several defined prevention goals that align with major drivers of chronic disease: tobacco cessation; controlling or reducing weight; lowering cholesterol; lowering blood pressure; and preventing the onset of diabetes, or for individuals who already have diabetes, improving disease management. These targets reflect conditions and risk factors that are common in Medicaid populations and that can often be improved through structured prevention programs, clinical preventive services, lifestyle interventions, and ongoing behavior change supports.

The incentive component is central to MIPCD. States were authorized to provide incentives to Medicaid beneficiaries who participate and demonstrate changes in health risk and outcomes. Importantly, the opportunity clarified that these incentives could not be counted when determining a beneficiarys eligibility for Medicaid or the amount of Medicaid benefits, and they also could not be treated as income or resources for other federally funded programs. That protection was designed to remove a common barrier to participation, namely the fear that receiving an incentive could inadvertently jeopardize public benefit eligibility.

From an administrative standpoint, this was a grant program (Funding Instrument Type: Grant) within the health activity category, with eligibility limited to state governments. CMS anticipated making around 10 awards. The published funding range set an award floor of 5,000,000 and a ceiling of 10,000,000, with no cost sharing or matching requirement. The funding opportunity number was CMS-1B1-11-001, and it was associated with CFDA 93.536, titled The Affordable Care Act Medicaid Incentives for Prevention of Chronic Disease Demonstration Project.

Key dates show that this opportunity was posted on February 23, 2011, with an application closing date of May 2, 2011, and an archive date of June 1, 2011. The announcement directed applicants needing help accessing the full posting to the Grants.gov Contact Center (1-800-518-4726) or support@grants.gov, reflecting that applications were expected to be handled through the federal grants portal.

Overall, MIPCD can be understood as a structured federal effort to help states use proven prevention strategies paired with beneficiary incentives to measurably reduce chronic disease risks in Medicaid populations, while ensuring incentives do not create unintended consequences for eligibility or benefits in Medicaid or other federal assistance programs.

Browse more business programs for Chronic Disease Research

Browse more opportunities from the same agency: Centers for Medicare Medicaid Services

Browse more opportunities from the same category: Health

Next opportunity: Urban Indian Health Program

Previous opportunity: BJA FY 11 Encouraging Innovation Field Initiated Programs

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CMS 1B1 11 001

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (CMS 1B1 11 001) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CMS 1B1 11 001", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.